Back to Journals » Clinical Ophthalmology » Volume 15

Ripasudil Endgame: Role of Rho-Kinase Inhibitor as a Last-Ditch-Stand Towards Maximally Tolerated Medical Therapy to a Patient of Advanced Glaucoma

Total article views   HTML views PDF downloads Totals
7,068 Dovepress* 6,335+ 499 6,834
PubMed Central* 733 114 847
Totals 7,068 613 7,681
*Since 24 June 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar